PH23931A - Diasteriomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids - Google Patents

Diasteriomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Info

Publication number
PH23931A
PH23931A PH36907A PH36907A PH23931A PH 23931 A PH23931 A PH 23931A PH 36907 A PH36907 A PH 36907A PH 36907 A PH36907 A PH 36907A PH 23931 A PH23931 A PH 23931A
Authority
PH
Philippines
Prior art keywords
thiolanylthio
penem
oxo
hydroxyethyl
diasteriomeric
Prior art date
Application number
PH36907A
Other languages
English (en)
Inventor
Robert Alfred Volkmann
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to PH38262A priority Critical patent/PH27045A/en
Publication of PH23931A publication Critical patent/PH23931A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
PH36907A 1987-05-11 1988-05-10 Diasteriomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids PH23931A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PH38262A PH27045A (en) 1987-05-11 1989-03-01 Diastereomeric 5R 6S-6-(1R-hydroxyethyl)-2- (CIS-1-OXO-3- thiolanylthio)-2-penem-3-carboxylic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/001114 WO1988008845A1 (en) 1987-05-11 1987-05-11 Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Publications (1)

Publication Number Publication Date
PH23931A true PH23931A (en) 1990-01-23

Family

ID=22202388

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36907A PH23931A (en) 1987-05-11 1988-05-10 Diasteriomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Country Status (27)

Country Link
US (2) US5013729A (pt)
EP (1) EP0294934B1 (pt)
JP (2) JPH0737463B2 (pt)
KR (1) KR900006840B1 (pt)
CN (2) CN1023016C (pt)
AT (1) ATE132869T1 (pt)
AU (1) AU603665B2 (pt)
CA (1) CA1338830C (pt)
CS (1) CS269999B2 (pt)
DD (1) DD270074A5 (pt)
DE (1) DE3854874T2 (pt)
DK (1) DK170443B1 (pt)
EG (1) EG18481A (pt)
ES (1) ES2081805T3 (pt)
FI (1) FI96423C (pt)
GR (1) GR3019094T3 (pt)
IE (1) IE70587B1 (pt)
IL (1) IL86288A0 (pt)
MA (1) MA21265A1 (pt)
MY (1) MY104306A (pt)
NZ (1) NZ224552A (pt)
PH (1) PH23931A (pt)
PL (1) PL159558B1 (pt)
PT (1) PT87443B (pt)
WO (1) WO1988008845A1 (pt)
YU (1) YU45059B (pt)
ZA (1) ZA883291B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352977A3 (en) * 1988-07-28 1991-08-07 Pfizer Inc. Stereoselective oxidation process
IL93262A (en) * 1989-02-09 1994-08-26 Pfizer Preparation of optically active 3-thiolnyl sulfonate esters
MX20084A (es) * 1989-03-28 1993-03-01 Pfizer Derivados de 2 -carbapenem antibacterianos
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
US5075439A (en) * 1990-08-17 1991-12-24 Pfizer Inc. Processes for (3S,4R)-3-[1(R)-t-butyl-dimethylsilyloxy)-ethyl]-4-[1-oxo-3-thiolanylthio(thiocarbonyl)thio]azetidin-2-ones and intermediates therefor
EP1712633A1 (en) * 2003-12-02 2006-10-18 Mercian Corporation Process for producing optically active tetrahydrothiophene derivative and method of crystallizing optically active tetrahydrothiophen-3-ol
JP2005314374A (ja) * 2004-03-31 2005-11-10 Daiso Co Ltd 3−ヒドロキシチオランの新規製法
KR100939347B1 (ko) 2005-07-20 2010-01-29 (주)카이로드 광학적으로 순수한 (s)-3-히드록시 피롤리딘의 제조방법
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
ES2355950T3 (es) * 2006-06-28 2011-04-01 Pfizer Products Inc. Profármacos de penem.
WO2008059367A1 (en) * 2006-11-14 2008-05-22 Pfizer Products Inc. Penem prodrugs
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
WO2009029554A2 (en) * 2007-08-24 2009-03-05 Codexis, Inc. Improved ketoreductase polypeptides for the stereoselective production of (r)-3-hydroxythiolane
CN105061394A (zh) * 2015-09-11 2015-11-18 北京工商大学 一种2-丙基-4-乙酰氧基四氢噻吩的制备方法
EP4382529A1 (en) 2022-12-07 2024-06-12 Bayer Consumer Care AG A process for preparing pure (3s)-pyrrolidin-3-ol and pure (3s)-pyrrolidin-3-ol hydrochloride

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130025B1 (en) * 1983-06-21 1987-07-08 Pfizer Inc. 2-alkylthiopenem derivatives
US4619924A (en) * 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
ATE66923T1 (de) * 1985-10-17 1991-09-15 Pfizer Verfahren fuer 2-(1-oxo-3-thiolanyl)-2penemantibiotika.
US4739047A (en) * 1985-10-17 1988-04-19 Pfizer Inc. Intermediates for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
ZA867809B (en) * 1985-10-17 1988-05-25 Pfizer Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
US4806637A (en) * 1986-03-17 1989-02-21 Schering Corporation 6-(Hydroxyethyl)-2-(heterocyclylthio)-penem-3-carboxylates
US4695626A (en) * 1986-07-29 1987-09-22 Pfizer Inc. 1-aza-4,5-dithiabicyclo [4.2.0] oct-2-en-8-one-2 carboxylate esters
PH24872A (en) * 1986-08-25 1990-12-26 Schering Corp (5r,6s,8r)-6-(-1-hydroxyethyl)-2-(3r-pyrrolidin-2-one-3-yl)thiopenem-3-carboxylic acid

Also Published As

Publication number Publication date
JPS63287781A (ja) 1988-11-24
MY104306A (en) 1994-03-31
PT87443A (pt) 1989-05-31
CN88102863A (zh) 1988-12-21
WO1988008845A1 (en) 1988-11-17
IE70587B1 (en) 1996-12-11
DD270074A5 (de) 1989-07-19
CN1036996C (zh) 1998-01-14
CS311988A2 (en) 1989-08-14
CN1023016C (zh) 1993-12-08
JPH07278137A (ja) 1995-10-24
ATE132869T1 (de) 1996-01-15
GR3019094T3 (en) 1996-05-31
CN1073442A (zh) 1993-06-23
PL272358A1 (en) 1989-10-30
CA1338830C (en) 1997-01-07
KR880013943A (ko) 1988-12-22
EP0294934A2 (en) 1988-12-14
DE3854874T2 (de) 1996-05-23
FI895369A0 (fi) 1989-11-10
DK170443B1 (da) 1995-09-04
EG18481A (en) 1993-06-30
ES2081805T3 (es) 1996-03-16
AU603665B2 (en) 1990-11-22
JP2544902B2 (ja) 1996-10-16
DE3854874D1 (de) 1996-02-22
EP0294934A3 (en) 1989-01-25
DK255888D0 (da) 1988-05-10
EP0294934B1 (en) 1996-01-10
KR900006840B1 (ko) 1990-09-22
NZ224552A (en) 1989-10-27
JPH0737463B2 (ja) 1995-04-26
YU90688A (en) 1989-12-31
YU45059B (en) 1991-06-30
IL86288A0 (en) 1988-11-15
FI96423C (fi) 1996-06-25
CS269999B2 (en) 1990-05-14
US5013729A (en) 1991-05-07
PT87443B (pt) 1992-08-31
AU1589688A (en) 1988-11-17
FI96423B (fi) 1996-03-15
IE881411L (en) 1988-11-11
ZA883291B (en) 1989-12-27
MA21265A1 (fr) 1988-12-31
DK255888A (da) 1989-02-07
PL159558B1 (pl) 1992-12-31
US5319103A (en) 1994-06-07

Similar Documents

Publication Publication Date Title
EG18481A (en) Diasteriomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
DK0490823T3 (pt)
AU2206188A (en) Azithromycin and derivatives as antiprotozoal agents
IT8220820A0 (it) Processo per l'idrogenolosi di esteri di acidi carbossilici.
GR3006674T3 (pt)
DE3461467D1 (en) 6-(aminomethyl)penicillanic acid 1,1-dioxide esters and intermediates therefor
DE3466877D1 (en) Crystalline salts of l or (s)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters and process
EP0090603A3 (en) Antibacterial compounds
YU43956B (en) Process for obtaining 2-(-ox-3-thiolanyl)-2-penem antibiotics
IT1177962B (it) Composti 1,2,4-triazolici,procedimento per produrli e composizioni farmaceutiche che li contengono
YU39339B (en) Process for obtaining the pure proteolytic enzyme cathepsin d from various animal organs
KR880022566U (ko) Vtr의 고속 역 재생기 주행 안정장치